Safety and feasibility of fecal microbiota transplantation for Parkinson’s disease patients: a protocol for a self-controlled interventional donor-FMT pilot study
View ORCID ProfileKaruna E.W. Vendrik, Vlada O. Bekker-Chernova, Ed J. Kuijper, Elisabeth M. Terveer, Jacobus J. van Hilten, View ORCID ProfileMaria Fiorella Contarino the FMT4PD study group
doi: https://doi.org/10.1101/2022.05.23.22274942
Karuna E.W. Vendrik
1Department of Medical Microbiology, Leiden University Medical Center, Leiden, the Netherlands
2Center for Infectious Disease Control, National Institute for Public Health and the Environment (Rijksinstituut voor Volksgezondheid en Milieu, RIVM), Bilthoven, the Netherlands
Vlada O. Bekker-Chernova
1Department of Medical Microbiology, Leiden University Medical Center, Leiden, the Netherlands
3Department of Neurology, Leiden University Medical Center, Leiden, the Netherlands
Ed J. Kuijper
1Department of Medical Microbiology, Leiden University Medical Center, Leiden, the Netherlands
2Center for Infectious Disease Control, National Institute for Public Health and the Environment (Rijksinstituut voor Volksgezondheid en Milieu, RIVM), Bilthoven, the Netherlands
Elisabeth M. Terveer
1Department of Medical Microbiology, Leiden University Medical Center, Leiden, the Netherlands
Jacobus J. van Hilten
3Department of Neurology, Leiden University Medical Center, Leiden, the Netherlands
Maria Fiorella Contarino
3Department of Neurology, Leiden University Medical Center, Leiden, the Netherlands
4Department of Neurology, Haga Teaching hospital, The Hague, the Netherlands
Posted May 25, 2022.
Safety and feasibility of fecal microbiota transplantation for Parkinson’s disease patients: a protocol for a self-controlled interventional donor-FMT pilot study
Karuna E.W. Vendrik, Vlada O. Bekker-Chernova, Ed J. Kuijper, Elisabeth M. Terveer, Jacobus J. van Hilten, Maria Fiorella Contarino
medRxiv 2022.05.23.22274942; doi: https://doi.org/10.1101/2022.05.23.22274942
Safety and feasibility of fecal microbiota transplantation for Parkinson’s disease patients: a protocol for a self-controlled interventional donor-FMT pilot study
Karuna E.W. Vendrik, Vlada O. Bekker-Chernova, Ed J. Kuijper, Elisabeth M. Terveer, Jacobus J. van Hilten, Maria Fiorella Contarino
medRxiv 2022.05.23.22274942; doi: https://doi.org/10.1101/2022.05.23.22274942
Subject Area
Subject Areas
- Addiction Medicine (319)
- Allergy and Immunology (621)
- Anesthesia (162)
- Cardiovascular Medicine (2329)
- Dermatology (205)
- Emergency Medicine (373)
- Epidemiology (11674)
- Forensic Medicine (10)
- Gastroenterology (690)
- Genetic and Genomic Medicine (3666)
- Geriatric Medicine (344)
- Health Economics (629)
- Health Informatics (2351)
- Health Policy (923)
- Hematology (339)
- HIV/AIDS (767)
- Medical Education (363)
- Medical Ethics (103)
- Nephrology (395)
- Neurology (3422)
- Nursing (193)
- Nutrition (515)
- Oncology (1794)
- Ophthalmology (530)
- Orthopedics (212)
- Otolaryngology (284)
- Pain Medicine (228)
- Palliative Medicine (66)
- Pathology (444)
- Pediatrics (1018)
- Primary Care Research (413)
- Public and Global Health (6071)
- Radiology and Imaging (1247)
- Respiratory Medicine (818)
- Rheumatology (375)
- Sports Medicine (320)
- Surgery (395)
- Toxicology (50)
- Transplantation (171)
- Urology (144)